GR860399B - Process for obtaining peptidic derivatives pepstatine analogs renines inhibitors and proteases acids - Google Patents

Process for obtaining peptidic derivatives pepstatine analogs renines inhibitors and proteases acids

Info

Publication number
GR860399B
GR860399B GR860399A GR860100399A GR860399B GR 860399 B GR860399 B GR 860399B GR 860399 A GR860399 A GR 860399A GR 860100399 A GR860100399 A GR 860100399A GR 860399 B GR860399 B GR 860399B
Authority
GR
Greece
Prior art keywords
proteases
renines
pepstatine
analogs
inhibitors
Prior art date
Application number
GR860399A
Other languages
English (en)
Inventor
Wagnon Jean
Callet Georges
Gagnol Jean-Pierre
Cazaubon Ctherine
Nisato Dino
Original Assignee
Sanofi Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8501982A external-priority patent/FR2577226B1/fr
Priority claimed from FR8501981A external-priority patent/FR2577225B1/fr
Application filed by Sanofi Sa, Inst Nat Sante Rech Med filed Critical Sanofi Sa
Publication of GR860399B publication Critical patent/GR860399B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GR860399A 1985-02-12 1986-02-11 Process for obtaining peptidic derivatives pepstatine analogs renines inhibitors and proteases acids GR860399B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8501982A FR2577226B1 (fr) 1985-02-12 1985-02-12 Analogues de pepstatine inhibiteurs de la renine et des proteases acides
FR8501981A FR2577225B1 (fr) 1985-02-12 1985-02-12 Derives peptidiques inhibiteurs de la renine et des proteases acides

Publications (1)

Publication Number Publication Date
GR860399B true GR860399B (en) 1986-06-12

Family

ID=26224369

Family Applications (2)

Application Number Title Priority Date Filing Date
GR860399A GR860399B (en) 1985-02-12 1986-02-11 Process for obtaining peptidic derivatives pepstatine analogs renines inhibitors and proteases acids
GR860398A GR860398B (en) 1985-02-12 1986-02-11 Process for obtaining peptidic derivatives of renine inhibitors and proteases acids

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR860398A GR860398B (en) 1985-02-12 1986-02-11 Process for obtaining peptidic derivatives of renine inhibitors and proteases acids

Country Status (11)

Country Link
US (2) US4725580A (el)
EP (2) EP0192554B1 (el)
AT (2) ATE52518T1 (el)
AU (2) AU606572B2 (el)
CA (2) CA1286846C (el)
DE (2) DE3671021D1 (el)
DK (2) DK64086A (el)
ES (2) ES8701782A1 (el)
GR (2) GR860399B (el)
NZ (2) NZ215097A (el)
PT (2) PT81991B (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2585708B1 (fr) * 1985-07-31 1989-07-07 Sanofi Sa Derives aminoalcools peptidiques inhibiteurs de la resine et des proteases acides, leur procede de preparation et leur application en therapeutique
US4599198A (en) * 1985-08-02 1986-07-08 Pfizer Inc. Intermediates in polypeptide synthesis
DE3626130A1 (de) * 1986-08-01 1988-02-11 Merck Patent Gmbh Aminosaeurederivate
DE3640535A1 (de) * 1986-11-27 1988-06-01 Merck Patent Gmbh Peptide
EP0284510A3 (en) * 1987-03-24 1990-08-22 Asahi Breweries, Ltd. N-[N alpha-(1(S)-carboxy-3-cyclohexyl-propyl)-1-lysyl] N-cyclopentylglycine as antihypertensives
US4874745A (en) * 1987-10-01 1989-10-17 Merck & Co., Inc. Renin-inhibitory pepstatin phenyl derivatives
US4980283A (en) * 1987-10-01 1990-12-25 Merck & Co., Inc. Renin-inhibitory pepstatin phenyl derivatives
US5162527A (en) * 1987-10-26 1992-11-10 Warner-Lambert Company Renin inhibitors, processes for preparing them, methods for using them, and compositions containing them
KR890701619A (ko) * 1987-10-26 1989-12-22 크리스틴 에이.트러트웨인 레닌 억제제, 그의 제조 방법, 그 사용 방법 및 이들을 함유한 조성물
US5164388A (en) * 1988-10-19 1992-11-17 Abbott Laboratories Heterocyclic peptide renin inhibitors
IL92011A0 (en) * 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
DK0383635T3 (da) * 1989-02-16 1995-11-20 Sankyo Co Peptider med renin-inhiberende virkning samt deres fremstilling og anvendelse
FR2646354B1 (fr) * 1989-04-27 1994-06-10 Sanofi Sa Utilisation de peptides inhibiteurs de proteases acides pour la preparation de medicaments utiles pour le traitement de maladies virales
US5238923A (en) * 1989-05-26 1993-08-24 Warner-Lambert Company Amino-substituted heterocycles as renin inhibitors
US5149692A (en) * 1989-12-21 1992-09-22 Warner-Lambert Company Bisalkoxyphosphinyl compounds as renin inhibitors
US5071837A (en) * 1990-11-28 1991-12-10 Warner-Lambert Company Novel renin inhibiting peptides
US5833946A (en) * 1995-06-06 1998-11-10 Bayer Corporation Dissemination of fungal infections: animal model and method of prophylaxis
AT407043B (de) * 1998-01-23 2000-11-27 Martin Dr Kratzel Simplifizierte pepstatin-a-analoga, deren herstellung und verwendung
US7247704B2 (en) 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
US7929913B2 (en) 2002-12-16 2011-04-19 Intel Corporation Adaptive receiver architecture
AU2012216230B2 (en) 2011-02-08 2017-05-25 Merck Patent Gmbh Amino statin derivatives for the treatement of arthrosis
AU2013295391B2 (en) 2012-07-24 2018-03-08 Merck Patent Gmbh Hydroxystatin derivatives for treatment of arthrosis
WO2014127881A1 (de) 2013-02-25 2014-08-28 Merck Patent Gmbh 2-amino-3,4-dihydrc-chinazolin derivate und ihre verwendung als cathepsin d inhibitoren
AU2014304950B2 (en) 2013-08-06 2019-09-12 Merck Patent Gmbh Intraarticular application of pepstatin in the case of arthrosis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1245217A (en) * 1981-12-10 1988-11-22 Joshua S. Boger Renin inhibitory peptides having phe su13 xx deletion
FR2531951A1 (fr) * 1982-08-17 1984-02-24 Sanofi Sa Derives peptidiques inhibiteurs de proteases acides, procede pour leur preparation et medicaments qui en contiennent
EP0114993B1 (en) * 1982-12-27 1990-05-16 Merck & Co. Inc. Renin inhibitory tripeptides

Also Published As

Publication number Publication date
ATE52518T1 (de) 1990-05-15
DK64186A (da) 1986-08-13
PT81990B (pt) 1988-03-03
CA1286847C (en) 1991-07-23
AU606572B2 (en) 1991-02-14
DE3683170D1 (de) 1992-02-13
GR860398B (en) 1986-06-12
ES551820A0 (es) 1986-12-16
PT81991B (pt) 1988-03-03
PT81991A (fr) 1986-03-01
ES8701782A1 (es) 1986-12-16
PT81990A (fr) 1986-03-01
NZ215096A (en) 1989-10-27
EP0192554A1 (fr) 1986-08-27
ES8701783A1 (es) 1987-01-01
DK64186D0 (da) 1986-02-10
CA1286846C (en) 1991-07-23
DK64086D0 (da) 1986-02-10
EP0193445B1 (fr) 1990-05-09
ES551821A0 (es) 1987-01-01
ATE71111T1 (de) 1992-01-15
EP0192554B1 (fr) 1992-01-02
US4725580A (en) 1988-02-16
AU5327386A (en) 1986-08-21
DK64086A (da) 1986-08-13
DE3671021D1 (de) 1990-06-13
AU5327286A (en) 1986-08-14
AU606312B2 (en) 1991-02-07
US4746648A (en) 1988-05-24
NZ215097A (en) 1990-04-26
EP0193445A1 (fr) 1986-09-03

Similar Documents

Publication Publication Date Title
GR860399B (en) Process for obtaining peptidic derivatives pepstatine analogs renines inhibitors and proteases acids
PT87652A (pt) Process for the preparation of peptide bobonic acid inhibitors of trypsin-like proteases
ZA858328B (en) Peptides selected from amino acid residues 11 to 23 of vip
EP0163237A3 (en) Di- and tri-peptidal renin inhibitors
GB8700204D0 (en) Pancreatic secretory trypsin inhibitor & variants
DE3462039D1 (en) Peptide derivatives, their preparation and use as elastase inhibitors
EP0187721A3 (en) Preparation of peptide substrates for virus-specified proteases
GR862021B (en) Process for obtaining aminoalcohols peptidic derivatives containing a tetrasubstituted carbon atom as inhibitors of renine and acid proteases
EP0209897A3 (en) Peptide enzyme inhibitors
IE852596L (en) Peptides active on the cns
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
HU9203968D0 (en) Thrombine inhibitors based on the amino acid sequence of hirudine
GR860532B (en) Process for obtainig peptidic derivtives of renine aminoalcohols inhibitor and acid proteases
DE3160757D1 (en) Amino acid and peptide esters of leuco-indo anilines, process for their preparation and agents containing these compounds for the detection of proteolytic enzymes
EP0156320A3 (en) Renin inhibitors containing homophe 8 and a c-terminal amide cycle
ZA86960B (en) Peptide derivatives,analogous to pepstatin,which inhibit renin and acid proteases
CA1267086C (en) METHOD OF ADMINISTRATION OF EAR DIURETIC PEPTIDES
FR2577226B1 (fr) Analogues de pepstatine inhibiteurs de la renine et des proteases acides
IT8419056A1 (it) Procedimento per l'isolamento di L-amminoacidi
YU43890B (en) Process for obtaining metalohelate of amino acids
ZA883953B (en) Peptide boronic acid inhibitors of trypsin-like proteases